Towards Biomanufacturing of Cell-Derived Matrices

Cell-derived matrices (CDM) are the decellularised extracellular matrices (ECM) of tissues obtained by the laboratory culture process. CDM is developed to mimic, to a certain extent, the properties of the needed natural tissue and thus to obviate the use of animals. The composition of CDM can be tai...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Weng Wan Chan, Fang Yu, Quang Bach Le, Sixun Chen, Marcus Yee, Deepak Choudhury
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/e9f023db645c48698034525e98ae8760
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e9f023db645c48698034525e98ae8760
record_format dspace
spelling oai:doaj.org-article:e9f023db645c48698034525e98ae87602021-11-11T17:20:41ZTowards Biomanufacturing of Cell-Derived Matrices10.3390/ijms2221119291422-00671661-6596https://doaj.org/article/e9f023db645c48698034525e98ae87602021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11929https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Cell-derived matrices (CDM) are the decellularised extracellular matrices (ECM) of tissues obtained by the laboratory culture process. CDM is developed to mimic, to a certain extent, the properties of the needed natural tissue and thus to obviate the use of animals. The composition of CDM can be tailored for intended applications by carefully optimising the cell sources, culturing conditions and decellularising methods. This unique advantage has inspired the increasing use of CDM for biomedical research, ranging from stem cell niches to disease modelling and regenerative medicine. However, while much effort is spent on extracting different types of CDM and exploring their utilisation, little is spent on the scale-up aspect of CDM production. The ability to scale up CDM production is essential, as the materials are due for clinical trials and regulatory approval, and in fact, this ability to scale up should be an important factor from the early stages. In this review, we first introduce the current CDM production and characterisation methods. We then describe the existing scale-up technologies for cell culture and highlight the key considerations in scaling-up CDM manufacturing. Finally, we discuss the considerations and challenges faced while converting a laboratory protocol into a full industrial process. Scaling-up CDM manufacturing is a challenging task since it may be hindered by technologies that are not yet available. The early identification of these gaps will not only quicken CDM based product development but also help drive the advancement in scale-up cell culture and ECM extraction.Weng Wan ChanFang YuQuang Bach LeSixun ChenMarcus YeeDeepak ChoudhuryMDPI AGarticlecell-derived matricesextracellular matrixdecellularised extracellular matrixbiomaterialshydrogelsbiomanufacturingBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11929, p 11929 (2021)
institution DOAJ
collection DOAJ
language EN
topic cell-derived matrices
extracellular matrix
decellularised extracellular matrix
biomaterials
hydrogels
biomanufacturing
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle cell-derived matrices
extracellular matrix
decellularised extracellular matrix
biomaterials
hydrogels
biomanufacturing
Biology (General)
QH301-705.5
Chemistry
QD1-999
Weng Wan Chan
Fang Yu
Quang Bach Le
Sixun Chen
Marcus Yee
Deepak Choudhury
Towards Biomanufacturing of Cell-Derived Matrices
description Cell-derived matrices (CDM) are the decellularised extracellular matrices (ECM) of tissues obtained by the laboratory culture process. CDM is developed to mimic, to a certain extent, the properties of the needed natural tissue and thus to obviate the use of animals. The composition of CDM can be tailored for intended applications by carefully optimising the cell sources, culturing conditions and decellularising methods. This unique advantage has inspired the increasing use of CDM for biomedical research, ranging from stem cell niches to disease modelling and regenerative medicine. However, while much effort is spent on extracting different types of CDM and exploring their utilisation, little is spent on the scale-up aspect of CDM production. The ability to scale up CDM production is essential, as the materials are due for clinical trials and regulatory approval, and in fact, this ability to scale up should be an important factor from the early stages. In this review, we first introduce the current CDM production and characterisation methods. We then describe the existing scale-up technologies for cell culture and highlight the key considerations in scaling-up CDM manufacturing. Finally, we discuss the considerations and challenges faced while converting a laboratory protocol into a full industrial process. Scaling-up CDM manufacturing is a challenging task since it may be hindered by technologies that are not yet available. The early identification of these gaps will not only quicken CDM based product development but also help drive the advancement in scale-up cell culture and ECM extraction.
format article
author Weng Wan Chan
Fang Yu
Quang Bach Le
Sixun Chen
Marcus Yee
Deepak Choudhury
author_facet Weng Wan Chan
Fang Yu
Quang Bach Le
Sixun Chen
Marcus Yee
Deepak Choudhury
author_sort Weng Wan Chan
title Towards Biomanufacturing of Cell-Derived Matrices
title_short Towards Biomanufacturing of Cell-Derived Matrices
title_full Towards Biomanufacturing of Cell-Derived Matrices
title_fullStr Towards Biomanufacturing of Cell-Derived Matrices
title_full_unstemmed Towards Biomanufacturing of Cell-Derived Matrices
title_sort towards biomanufacturing of cell-derived matrices
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/e9f023db645c48698034525e98ae8760
work_keys_str_mv AT wengwanchan towardsbiomanufacturingofcellderivedmatrices
AT fangyu towardsbiomanufacturingofcellderivedmatrices
AT quangbachle towardsbiomanufacturingofcellderivedmatrices
AT sixunchen towardsbiomanufacturingofcellderivedmatrices
AT marcusyee towardsbiomanufacturingofcellderivedmatrices
AT deepakchoudhury towardsbiomanufacturingofcellderivedmatrices
_version_ 1718432152587075584